SNSE- Sensei Biotherapeutics, Inc.

Name: Sensei Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Sensei Biotherapeutics, Inc. (SNSE) has 9 insiders with recent SEC Form 4 filings, including 7 buys and 18 sells. SNSE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
COO	Parikh Anand Kiran	1.24M	$29.00M	-
?	Cambrian Biopharma Inc	155.6K	$3.64M	-
Other	Craver Josiah	80.0K	$1.87M	-
Dir	Donenberg Phillip B.	23.1K	$540.5K	-
Dir	Holmen Bob	19.0K	$444.6K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 9, 2025	Peyer James	-	Sale+OE	6,612	$8.25	$54,574.77	-1.0%	+270.1%	-
Dec 9, 2025	Cambrian Biopharma Inc	-	Sale+OE	6,612	$8.25	$54,574.77	-1.0%	+270.1%	-
Dec 5, 2025	Cambrian Biopharma Inc	-	Sell	21,295	$10.93	$232,689.97	-3.1%	+213.8%	-
Dec 5, 2025	Peyer James	-	Sell	21,295	$10.93	$232,689.97	-3.1%	+213.8%	-
Sep 11, 2023	Celebi John	President And CEO	Buy	500	$0.85	$425.00	+0.5%	-17.8%	-31.2%
Jun 1, 2023	Apeiron Investment Group Ltd.48	10% Owner	Sell	3,441,661	$1.58	$5,437,824.38	-100%	-29.5%	-49.3%
Feb 23, 2023	Apeiron Investment Group Ltd.48	10% Owner	Buy	2,200	$1.61	$3,539.03	-	-0.6%	-53.4%
Mar 2, 2022	Cambrian Biopharma Inc	10% Owner	Buy	1,203	$3.20	$3,849.60	-	-43.5%	-49.4%
Mar 2, 2022	Peyer James	Director, 10% Owner	Buy	1,203	$3.20	$3,849.60	-	-43.5%	-49.4%
Mar 1, 2022	Cambrian Biopharma Inc	10% Owner	Buy	2,500	$3.60	$9,000.00	-	-46.2%	-52.7%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC